RxDoctor Payments DataLook up a doctor →

Kenneth Hahn, DO

Family Medicine · Thornton, CONPI 1922005818

Payments from drug & device makers

$19,716in general payments, 2019–2025

Across 1,132 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • AstraZeneca$2K
  • Novo Nordisk$2K
  • Boehringer Ingelheim$1K
  • Lilly USA, LLC$1K
  • Amgen$1K
  • plus $9K from 54 others

What the payments were for

  • Food & beverage$19,716100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)176$2,947
AstraZeneca(2 entities)113$2,245
Novo Nordisk134$2,019
Boehringer Ingelheim72$1,380
Lilly USA, LLC93$1,187
Amgen(2 entities)63$1,097
GSK57$1,020
Pfizer58$945
Bayer27$577
Johnson & Johnson29$496
Merck41$465
Novartis22$407
Astellas Pharma US Inc17$381
Sanofi-aventis U.S. LLC22$373
Medtronic(4 entities)12$307
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC18$287
Abbott16$285
Biohaven Pharmaceutical Holding Company Ltd.7$181
Eisai Inc.9$180
Grifols USA, LLC7$158
Teva Pharmaceuticals USA, Inc.7$157
Takeda Pharmaceuticals U.S.A., Inc.7$155
Otsuka America Pharmaceutical, Inc.7$148
Amarin Pharma, Inc.7$121
Exact Sciences5$117
Cranial Technologies, Inc7$112
Hologic Sales And Service, LLC7$104
Nestle Healthcare Nutrition Inc.6$103
Biohaven Pharmaceuticals, Inc.4$87
Optinose US, Inc.4$80
Seqirus USA Inc3$75
Esperion Therapeutics, Inc.3$74
Lucid Diagnostics Inc.1$68
Vanda Pharmaceuticals Inc.2$67
Corium, LLC4$66
IBSA Pharma Inc.4$65
E.r. Squibb & Sons, L.L.C.3$64
Edwards Lifesciences2$59
Idorsia Pharmaceuticals US Inc3$48
Dexcom, Inc.2$47
Ironshore Pharmaceuticals Inc.2$46
Daiichi Sankyo Inc.2$44
Biogen3$44
Corcept Therapeutics2$41
Aimmune Therapeutics, Inc.2$39
Jazz Pharmaceuticals Inc.2$38
Cleerly, Inc.1$38
Therapeuticsmd, Inc.3$37
Dermira, Inc.2$36
Gilead2$35
Heartflow, Inc.2$34
Sanofi Pasteur Inc.2$31
Inogen, Inc.1$27
Coopersurgical, Inc.2$26
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$26
Organon1$24
Abiomed1$23
ANI Pharmaceuticals, Inc.1$23
Shire North American Group Inc1$23
QOL Medical, LLC1$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,716 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$60,935
Medicare patients
187
Services billed
773

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban91$102,899
TrulicityDulaglutide64$69,231
FarxigaDapagliflozin Propanediol49$52,165
JardianceEmpagliflozin36$47,550
XareltoRivaroxaban26$43,442
Breztri AerosphereBudesonide/Glycopyr/Formoterol37$38,121
JanuviaSitagliptin Phosphate23$33,794
OzempicSemaglutide24$29,183
MounjaroTirzepatide24$27,881
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$26,680
RybelsusSemaglutide12$18,923
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr21$17,673
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$9,161
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog17$6,675
Fluticasone-SalmeterolFluticasone Propion/Salmeterol24$4,423

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$945$102,89991 claims
Lilly USA, LLCTrulicity, Mounjaro$1,187$97,11288 claims
AstraZenecaFarxiga, Breztri Aerosphere$2,245$90,28686 claims
Boehringer IngelheimJardiance, Stiolto Respimat$1,380$56,71147 claims
Novo NordiskOzempic, Rybelsus$2,019$48,10636 claims
GSKTrelegy Ellipta, Anoro Ellipta$1,020$44,35349 claims
Johnson & JohnsonXarelto$496$43,44226 claims
MerckJanuvia$465$33,79423 claims
Daiichi Sankyo Inc.Welchol$44$2,90411 claims
AbbVieSynthroid$2,947$2,38417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Thornton

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →